Immunotherapy

Cancer immunotherapy (sometimes called immuno-oncology) is the stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight the disease.

Read more in the app

Unlocking the potential to better target cancer with immunotherapy

AI analysis of PET/CT images can predict side effects of immunotherapy in lung cancer - EurekAlert

Researchers find metabolic mechanism that blocks immune response, immunotherapy in cancer - EurekAlert

Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer - EurekAlert

Immunotherapy boosts survival of advanced Hodgkin lymphoma

92% Survival Rate: Immunotherapy Boosts Survival of Advanced Hodgkin Lymphoma

Immune signatures may predict adverse events from immunotherapy

Disrupting Asxl1 gene prevents T-cell exhaustion, improving immunotherapy

An epigenetic characteristic help predict efficacy of immunotherapy in multiple myeloma - EurekAlert

Immunotherapy for gum disease? Study in mice shows promise

Immunotherapy for gum disease? Study in mice shows promise - EurekAlert

Combination treatment improves response to immunotherapy for lung cancer

Long-term metastatic melanoma survival dramatically improves on immunotherapy, study finds

Immunotherapy shows promise for men with specific types of prostate cancer

Long-term metastatic melanoma survival dramatically improves on immunotherapy - EurekAlert

Five key factors predict the response of cancer patients to immunotherapy

Immunotherapy before and after lung cancer surgery reduces death risk, disease recurrence - EurekAlert

Gut bacteria influence responses to immunotherapy in patients with asbestos related cancer

Gut bacteria influence responses to immunotherapy in patients with asbestos related cancer, Leicester study finds - EurekAlert

Drug bypasses suppressive immune cells to unleash immunotherapy